Genetic Basis of Disease (Lectures 9 – 11) Flashcards
(9 cards)
Difference between sex-linked and autosomal inheritance
Sex-linked inheritance involves genes on the sex chromosomes (typically X). Disorders like red-green color blindness are X-linked and more common in males.
Autosomal inheritance refers to genes on non-sex chromosomes (autosomes). Disorders can be dominant (e.g., Achondroplasia) or recessive (e.g., Phenylketonuria).
Meaning of dominance and recessiveness
A dominant allele expresses its trait with just one copy (heterozygous).
A recessive allele must be present in both gene copies (homozygous) to manifest the trait.
Achondroplasia = dominant example, PKU = recessive example.
That mitochondria have genes
Mitochondria carry their own DNA, inherited maternally.
Mutations in mitochondrial genes affect energy production and can cause mitochondrial diseases.
Difference between simple and complex genetic diseases
Simple (monogenic) diseases result from mutations in a single gene (e.g., CF, SMA).
Complex (polygenic) diseases involve many genes and environmental factors (e.g., obesity, schizophrenia).
That cancer is a genetic disease
Cancer is driven by mutations in genes regulating the cell cycle, growth, and apoptosis.
Mutations in oncogenes or tumour suppressor genes disrupt normal control, leading to uncontrolled cell growth.
Health and disease as an interaction between genes and environment
Traits like obesity or schizophrenia reflect an interaction: genetic predispositions + lifestyle/environmental influences.
Genetics loads the gun, environment pulls the trigger.
Basic properties of the human genome
The human genome has ~20,000 genes across 23 chromosome pairs (22 autosomes + X/Y).
Genetic diversity arises from SNPs, alleles, recombination, and mutations.
How disease-associated genes can be identified
GWAS (Genome-Wide Association Studies) identify genetic variants linked to diseases.
Polygenic Risk Scores sum risk alleles to predict disease susceptibility in complex traits.
How understanding genes enables gene therapy design
SMA: Nusinersen promotes functional protein production.
CML: Imatinib blocks abnormal tyrosine kinase activity from the BCR-ABL fusion gene.